3577-01-3 (头孢来星,Cephaloglycin)

CAS号:
3577-01-3
中文名称:
头孢来星
英文名称:
Cephaloglycin
分子式:
C18H19N3O6S
分子量:
405.424963235855
简介:
Cefaloglycin (Cephaloglycin) 是一种具有口服活性的肾毒性 β-内酰胺类 (β-lactam) 头孢菌素抗生素,具有抗菌活性。Cefaloglycin 对肠球菌以外的革兰氏阳性球菌 (Gram-Positive cocci) 有活性。Cefaloglycin 对线粒体底物的摄取和呼吸也具有毒性。

头孢来星(3577-01-3)名称与标识符

名称

中文别名:
头孢来星;
英文别名:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 3-[(acetyloxy)methyl]-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-,(6R,7R)-;Cephaloglycin;(6R)-3-acetoxymethyl-7t-((R)-2-amino-2-phenyl-acetylamino)-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefaloglicina;Cefaloglycin;Cefaloglycine;Cefaloglycinum;Cephaloglycin anhydrous;Cephaloglycine;Cephaoglycin acid;D-Cephaloglycine;Kafocin;HSDB 3214;Kefocin;7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup 3)-cephem-4-carboxylic acid;UNII-HD2D469W6U;7-(D-alpha-Aminophenyl-acetamido)cephalosporanic acid;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6R-(6alpha,7beta(R*)))-;3-((Acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid;SCHEMBL2947;NCGC00521078-02;CEPHALOGLYCIN [MI];FUBBGQLTSCSAON-PBFPGSCMSA-N;Cefaloglycine [INN-French];NS00011574;(6R,7R)-7-((R)-2-AMINO-2-PHENYLACETAMIDO)-3-(HYDROXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID ACETATE (ESTER);CEG;Cefaloglycinum (INN-Latin);7-(2-D-alpha-Aminophenylacetamido)cephalosporanic acid;(6R,7R)-3-(acetoxymethyl)-7-(((2R)-2-amino-2-phenylacetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid;Cefaloglycine (INN-French);5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-7-[[(2R)-aminophenylacetyl]amino]-8-oxo-,(6R,7R)-;EINECS 222-696-7;HD2D469W6U;(6R,7R)-3-(acetoxymethyl)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-((AMINOPHENYLACETYL)AMINO)-8-OXO-, (6R-(6alpha,7beta(R*)));3-acetoxymethyl-7beta-[(2R)-2-amino-2-phenylacetamido]-3,4-didehydrocepham-4-carboxylic acid;7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)octane-2-carboxylic acid, acetate inner salt;Cefaloglycinum [INN-Latin];5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(2-AMINO-2-PHENYLACETAMIDO)-3-(HYDROXYMETHYL)-8-OXO-, ACETATE (ES///;(6R,7R)-3-[(acetyloxy)methyl]-7-{[(2R)-2-amino-2-phenylacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-((AMINOPHENYLACETYL)AMINO)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*)));Cefaloglycin [INN];DTXCID402781;Epitope ID:174844;Cefaloglycin (JAN);Cefaloglicina [INN-Spanish];5-Thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic acid, 3-((acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-, (6R-(6alpha,7beta(R*))), dihydrate;D01949;DB00689;Cefaloglycin dihydrate;7-(D-alpha-Aminophenylacetamido)-cephalosporanic acid dihydrate;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-, acetate (ester), D-;(6R,7R)-3-[(acetyloxy)methyl]-7-[(2R)-2-amino-2-phenylacetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;7-(2-Amino-2-phenylacetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid acetate (ester);Kefglycin;CHEBI:34613;GTPL12193;D-(-)-Cephaloglycin;3577-01-3;Lilly 39435;Cefaloglicina (INN-Spanish);DTXSID4022781;CHEMBL1200971;7-(D-2-Amino-2-phenylacetamido)-3-acetoxymethyl-delta(sup3)-cephem-4-carboxylic acid;3-acetoxymethyl-7beta-((2R)-2-amino-2-phenylacetamido)-3,4-didehydrocepham-4-carboxylic acid;Cephaloglycin anhdyous;Cephaloglycin dihydrate;CEFALOGLYCIN [WHO-DD];EN300-19734691;CEPHALOGLYCIN [HSDB];5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 3-((ACETYLOXY)METHYL)-7-((AMINOPHENYLACETYL)AMINO)-8-OXO-, (6R-(6AL///;CEFALOGLYCIN [JAN];Q5057214;HY-16137;7-(D-ALPHA-AMINOPHENYLACETAMIDO)CEPHALOSPORANIC ACID;CS-0006156;7-(2-AMINO-2-PHENYLACETAMIDO)-3-(HYDROXYMETHYL)-8-OXO-5 -THIA-1-AZABICYCLO;DA-62180;

标识符

MDL:
MFCD00056878
InChIKey:
FUBBGQLTSCSAON-PBFPGSCMSA-N
Inchi:
1S/C18H19N3O6S/c1-9(22)27-7-11-8-28-17-13(16(24)21(17)14(11)18(25)26)20-15(23)12(19)10-5-3-2-4-6-10/h2-6,12-13,17H,7-8,19H2,1H3,(H,20,23)(H,25,26)/t12-,13-,17-/m1/s1
SMILES:
S1CC(COC(C)=O)=C(C(=O)O)N2C([C@H]([C@@H]12)NC([C@@H](C1C=CC=CC=1)N)=O)=O

头孢来星(3577-01-3)物化性质

实验特性

  • LogP : 1.01720
  • PSA : 164.33000
  • 折射率 : 1.6390 (estimate)
  • 沸点 : 217.4°C (rough estimate)
  • 熔点 : 236.5°C (rough estimate)
  • 闪点 : 414.5 ℃
  • 密度 : 1.3328 (rough estimate)

计算特性

  • 精确分子量 : 405.09900
  • 氢键供体数量 : 3
  • 氢键受体数量 : 9
  • 可旋转化学键数量 : 8
  • 同位素质量 : 405.099
  • 重原子数量 : 28
  • 复杂度 : 718
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 3
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : _3
  • 拓扑分子极性表面积 : 164A^2

头孢来星(3577-01-3)安全信息

头孢来星(3577-01-3)推荐厂家 更多厂家(5)

公司名称手机号/电话联系人QQ微信询单
上海源叶生物科技有限公司 15026964105
15026964105
汤思磊 2881489226
询单
上海楷森生物科技有限公司 17558870519
175-58870519
赵经理 3003926540
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
上海阿拉丁生化科技股份有限公司 13167063860
13167063860
阿拉丁 3004013043
询单
广州嘉源化工有限公司 15342355425苏生 2355880519
询单

头孢来星(3577-01-3)相关文献